Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PAR | PUBM |
|---|---|---|
| Price | $14.78 | $18.57 |
| Change today | ▲ 1.93% | ▲ 1.20% |
| Market cap | $611.34M | $845.86M |
| Return, 3 months | -11.7% | +36.9% |
| Return, year to date | -59.3% | +109.4% |
| Return, 1 year | -60.3% | +108.9% |
| P/E (TTM) | -8.4 | -64.0 |
| P/B | 0.8 | 3.5 |
| P/E percentile vs own 5y | 89th | 6th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +18.7% | +10.5% |
| Net profit growth (YoY) | +19.7% | +76.9% |
| Gross margin | 42.2% | 64.4% |
| Operating margin | -11.5% | -5.0% |
| Net margin | -14.5% | -4.7% |
| Return on equity | -8.6% | -5.6% |
| Analyst target vs. price | +64.4% | +13.1% |
| Analyst buy share | 67% | 90% |
| RSI (14) | 41 | 61 |
| 30-day volatility | 47.5% | 37.6% |
| Max drawdown, 1 year | -70.6% | -42.8% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
